Human leukocyte antigen-DQ beta 1 chain (DQB1) gene polymorphisms are associated with dilated cardiomyopathy: A systematic review and meta-analysis

Heart and Lung: Journal of Acute and Critical Care

Volumn 41, Issue 4, 2012, Pages 360-367

  Li, Xiaoping ^a   Luo, Rong ^b   Jiang, Rongjian ^c   Chen, Ruizhen ^d   Hua, Wei ^a  

^a FUWAI HOSPITAL   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

Dilated cardiomyopathy; HLA DQB1; Meta analysis

Indexed keywords

HLA DQB1 ANTIGEN;

ALLELE; CASE CONTROL STUDY; CONGESTIVE CARDIOMYOPATHY; DNA POLYMORPHISM; DQB1 GENE; GENE; GENE FREQUENCY; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; GENOME-WIDE ASSOCIATION STUDY; HLA-DQ BETA-CHAINS; HUMANS;

EID: 84862899611     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2012.01.005     Document Type: Review

References (37)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996, 93:841-842.
2. Luk A., Ahn E., Soor G.S., Butany J. Dilated cardiomyopathy: a review. J Clin Pathol 2009, 62:219-225.
3. Stehlik J., Edwards L.B., Kucheryavaya A.Y., Aurora P., Christie J.D., Kirk R., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 2010, 29:1089-1103.
4. Manolio T.A., Baughman K.L., Rodeheffer R., Pearson T.A., Bristow J.D., Michels V.V., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of National, Heart, Lung, and Blood InstituteWorkshop). Am J Cardiol 1992, 69:1458-1466.
5. Mohan S.B., Parker M., Wehbi M., Douglass P. Idiopathic dilated cardiomyopathy: a common but mystifying cause of heart failure. Cleve Clin J Med 2002, 69:481-487.
6. Felker G.M., Hu W., Hare J.M., Hruban R.H., Baughman K.L., Kasper E.K. The spectrum of dilated cardiomyopathy: The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 1999, 78:270-283.
7. Grünig E., Tasman J.A., Kücherer H., Franz W., Kübler W., Katus H.A. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998, 31:186-194.
8. Bender J.R. Idiopathic dilated cardiomyopathy: an immunologic, genetic, or infectious disease, or all of the above?. Circulation 1991, 83:704-706.
9. Carlquist J.F., Menlove R.L., Murray M.B., O'Connell J.B., Anderson J.L. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: validation study and meta-analysis of published HLA association studies. Circulation 1991, 83:515-522.
10. McKenna C.J., Codd M.B., McCann H.A., Sugrue D.D. Idiopathic dilated cardiomyopathy, familial prevalence and HLA distribution. Heart 1997, 77:549-552.
11. Maharaj B., Hammond M.G. HLA-A, B, DR and DQ antigens in black patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1990, 65:1402-1403.
12. Wang Q., Liao Y., Gong F., Mao H., Zhang J. HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy. Tongji Med Univ J 2000, 20:141-142.
13. Carlquist J.F., Ward R.H., Husebye D., Feolo M., Anderson J.L. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol 1994, 74:918-920.
14. Portig I., Sandmoeller A., Kreilinger S., Maisch B. HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis. Autoimmunity 2009, 42:33-40.
15. Liu W., Li W.M., Sun N.L. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann Hum Genet 2005, 69:382-388.
16. Limas C., Limas C.J., Boudoulas H., Bair R., Sparks L., Graber H., et al. HLA-DQA1 and -DQB1 gene haplotypes in familial cardiomyopathy. Am J Cardiol 1994, 74:510-512.
17. Nishi H., Kimura A., Fukuta S., Kusukawa R., Kawamura K., Nimura Y., et al. Genetic analysis of dilated cardiomyopathy-HLA and immunoglobulin genes may confer susceptibility. Jpn Circ J 1992, 56:1054-1061.
18. Nishi H., Koga Y., Koyanagi T., Harada H., Imaizumi T., Toshima H., et al. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J Mol Cell Cardiol 1995, 27:2385-2392.
19. Rodríguez-Pérez J.M., Fragoso J.M., Alvarez-León E., Martínez-Rodríguez N., Gallardo G.J., Inés-Real S., et al. MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy. Exp Mol Pathol 2007, 82:49-52.
20. Limas C.J., Limas C., Goldenberg I.F., Blair R. Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J 1995, 129:1141-1144.
21. Lozano M.D., Rubocki R.J., Wilson J.E., McManus B.M., Wisecarver J.L. Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis Treatment Trial Investigators. J Card Fail 1997, 3:97-103.
22. Mahjoub S., Mehri S., Ghazouani E., Ouarda F., Boussada R., Zaroui A., et al. HLA class II polymorphisms in Tunisian patients with dilated cardiomyopathy. Tissue Antigens 2010, 75:679-683.
23. Luppi P., Alexander A., Bertera S., Noonan K., Trucco M. The same HLA-DQ alleles determine either susceptibility or resistance to different coxsackievirus-mediated autoimmune diseases. J Biol Regul Homeost Agents 1999, 13:14-26.
24. Limas C.J., Kroupis C., Haidaroglou A., Cokkinos D.V. Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations. Eur J Clin Invest 2002, 32:74-78.
25. Petitti D.B. Statistical methods in meta-analysis. Meta-analysis, decision analysis, and cost-effectiveness analysis 1994, 90-114. Oxford University Press, New York. D.B. Petitti (Ed.).
26. Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Br Heart J 1980, 44:672-673. World Health Organization.
27. Arbustini E., Gavazzi A., Pozzi R., Grasso M., Pucci A., Campana C., et al. The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am J Cardiol 1989, 64:991-995.
28. Anderson J.L., Carlquist J.F., Lutz J.R., DeWitt C.W., Hammond E.H. HLA-A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol 1984, 53:1326-1330.
29. Caforio A.L., Martinetti M., Schwarz G., Bonifacio E., Gavazzi A., Graziano G., et al. Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992, 39:236-240.
30. Martinetti M., Dugoujon J.M., Caforio A.L., Schwarz G., Gavazzi A., Graziano G., et al. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy. Hum Immunol 1992, 35:193-199.
31. Ghosh N., Haddad H. Recent progress in the genetics of cardiomyopathy and its role in the clinical evaluation of patients with cardiomyopathy. Curr Opin Cardiol 2011, 26:155-164.
32. Hershberger R.E., Morales A., Siegfried J.D. Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genet Med 2010, 12:655-667.
33. Caforio A.L., Goldman J.H., Baig M.K., Mahon N.J., Haven A.J., Souberbielle B.E., et al. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail 2001, 3:155-163.
34. Jahns R., Boivin V., Lohse M.J. Beta(1)-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med 2006, 16:20-24.
35. Taneja V., David C.S. Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice. J Autoimmun 2009, 33:260-269.
36. Liu W., Li W.M., Sun N.L. Relationship between HLA-DQA1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy. Chin Med J [Engl] 2004, 117:1449-1452.
37. Villard E., Perret C., Gary F., Proust C., Dilanian G., Hengstenberg C., et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 2011, 32:1065-1076.